U
ALKS icon

UBS’s Alkermes ALKS Stock Holding History

UBS’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-100
Closed -$3K – 10353
2013
Q3 		$3K Sell
100
-100
-50% -$3.25K ﹤0.01% 9725
2013
Q2 		$6K Buy
+200
New +$5.83K ﹤0.01% 9090

Other funds holding ALKS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

UBS's ALKS Position: Q3 2014 in Review

UBS reduced its Alkermes (ALKS) stake by 25% in Q3 2014, selling an estimated $1.78M and leaving 118,317 shares worth $5.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2017.

UBS first reported a position in ALKS in Q2 2013 and has held it in 6 quarters since. The position peaked at $7.95M in Q2 2014. 204 funds tracked by Wall St. Rank hold ALKS as of Q3 2014.

  • UBS held 118,317 shares of Alkermes worth $5.07M as of Q3 2014.
  • UBS sold 39,629 Alkermes shares in Q3 2014, an estimated $1.78M.
  • Alkermes made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2017 holding.
  • UBS first reported a position in Alkermes in Q2 2013 and has held it in 6 quarters since.
  • UBS's Alkermes position peaked at $7.95M in Q2 2014.
  • 204 funds tracked by Wall St. Rank held Alkermes as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.